ANTICOAGULANT MONITORING
ANTI-Xa
LYOPHILIZED PLASMAS

TECHNOVIEW RIVAROXABAN CONT LOW

Cat Num. Conditioning  
4-50901725 x 1,0 mL
Set of low control plasmas to be used for the quality control of rivaroxaban measurements.
Control Low Plasmas are prepared from citrated plasmas supplemented with around 60 ng/mL of rivaroxaban.
Characteristics
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer. In a number of countries it is marketed as Xarelto®.

THEY TRUST US

OUR PARTNERS